Skip to content

Opus Genetics IRD Warrant financing costs

Warrant financing costs at other companies

Evommune
 logo
Evommune EVMN
$150
Evommune
 logo
Evommune EVMN
$150
Precigen logo
PrecigenPGEN
$0-100%
NovaGold Resources logo
NovaGold ResourcesNG
$0-100%
General Purpose Acquisition Corp.
 logo
General Purpose Acquisition Corp. GPAC
$648.86K
Plug Power logo
Plug PowerPLUG
$49.12M

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept ird:WarrantFinancingCostsReclassifiedToFinancingActivities.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's warrant financing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's warrant financing costs?
Opus Genetics (IRD) reported warrant financing costs of $0 in Q1 2026.
How has Opus Genetics's warrant financing costs changed year-over-year?
Opus Genetics's warrant financing costs decreased by 100.0% year-over-year, from $1.37M to $0.
What does warrant financing costs mean?
Costs directly associated with the issuance of warrants that are categorized as financing activities rather than operating expenses. Tracking these costs helps investors understand the true expense burden of raising capital through derivative-linked instruments.